RhumbLine Advisers’s Cross Country Healthcare CCRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $688K | Sell |
|
|||||
|
2025
Q2 | $649K | Sell |
|
|||||
|
2025
Q1 | $769K | Sell |
|
|||||
|
2024
Q4 | $973K | Sell |
|
|||||
|
2024
Q3 | $964K | Sell |
|
|||||
|
2024
Q2 | $1.51M | Sell |
|
|||||
|
2024
Q1 | $2.1M | Buy |
|
|||||
|
2023
Q4 | $2.5M | Buy |
|
|||||
|
2023
Q3 | $2.62M | Sell |
|
|||||
|
2023
Q2 | $3.02M | Sell |
|
|||||
|
2023
Q1 | $2.5M | Buy |
|
|||||
|
2022
Q4 | $2.85M | Sell |
|
|||||
|
2022
Q3 | $3.06M | Buy |
|
|||||
|
2022
Q2 | $2.21M | Buy |
|
|||||
|
2022
Q1 | $2.22M | Buy |
|
|||||
|
2021
Q4 | $2.77M | Sell |
|
|||||
|
2021
Q3 | $2.25M | Sell |
|
|||||
|
2021
Q2 | $1.96M | Sell |
|
|||||
|
2021
Q1 | $1.57M | Buy |
|
|||||
|
2020
Q4 | $1.1M | Buy |
|
|||||
|
2020
Q3 | $722K | Sell |
|
|||||
|
2020
Q2 | $849K | Buy |
|
|||||
|
2020
Q1 | $916K | Buy |
|
|||||
|
2019
Q4 | $1.5M | Buy |
|
|||||
|
2019
Q3 | $1.27M | Buy |
|
|||||
|
2019
Q2 | $1.11M | Buy |
|
|||||
|
2019
Q1 | $757K | Buy |
|
|||||
|
2018
Q4 | $777K | Buy |
|
|||||
|
2018
Q3 | $769K | Sell |
|
|||||
|
2018
Q2 | $1.01M | Buy |
|
|||||
|
2018
Q1 | $946K | Buy |
|
|||||
|
2017
Q4 | $1.07M | Buy |
|
|||||
|
2017
Q3 | $1.02M | Buy |
|
|||||
|
2017
Q2 | $870K | Buy |
|
|||||
|
2017
Q1 | $907K | Buy |
|
|||||
|
2016
Q4 | $705K | Buy |
|
|||||
|
2016
Q3 | $503K | Sell |
|
|||||
|
2016
Q2 | $628K | Sell |
|
|||||
|
2016
Q1 | $552K | Buy |
|
|||||
|
2015
Q4 | $723K | Buy |
|
|||||
|
2015
Q3 | $562K | Buy |
|
|||||
|
2015
Q2 | $503K | Sell |
|
|||||
|
2015
Q1 | $589K | Buy |
|
|||||
|
2014
Q4 | $583K | Buy |
|
|||||
|
2014
Q3 | $399K | Hold |
|
|||||
|
2014
Q2 | $280K | Buy |
|
|||||
|
2014
Q1 | $327K | Sell |
|
|||||
|
2013
Q4 | $417K | Sell |
|
|||||
|
2013
Q3 | $270K | Sell |
|
|||||
|
2013
Q2 | $235K | Buy |
|